Immatics at the NeoAg Summit (Nov 20-22) in Boston, MA

| News, USA

Weaponizing Neoantigens to Create Truly Personalized Cancer Vaccines and Cellular Immunotherapies

Meet Immatics at the 4th Annual NeoAg Summit in Boston, MA and get latest updates about how to advance neoantigens to target tumors and how to bring personalized vaccines to market.


Thursday, Nov 21, 2.15pm – 2.45pm

Prediction & Discovery track: Standardizing Neoantigen Discovery Processes to Uncover Best Validation Methods

Antigens that Matter - Highly Personalized Immunotherapy Approaches Applying the XPRESIDENT® Technology

Speaker: Norbert Hilf, VP Translational Development


More information on the NeoAg Summit find here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.